David Suarez1, Josep Maria Haro, Diego Novick, Susana Ochoa. 1. Research & Development Unit, Sant Joan de Déu-SSM, Fundació Sant Joan de Déu, RETICS RD06/0011(REM-TAP Network), Sant Boi, Barcelona, Spain. david.suarez.lamas@gmail.com
Abstract
OBJECTIVE: We review marginal structural models (MSMs) and show how they are useful when comparing the effects of multiple treatments on outcomes in observational studies. Until now, MSMs have not been used to compare the effects of more than two treatments. STUDY DESIGN AND SETTING: To illustrate the application of MSMs when patients may receive several treatments, we have reanalyzed the effects of antipsychotic medication on achieving remission in schizophrenia using data from the SOHO study, a 3-year observational study of health outcomes associated with the treatment of schizophrenia. RESULTS: The MSM results were, in general, consistent with but less statistically significant than those obtained using conventional methods. The MSM also showed qualitative differences in some comparisons in which the conventional analysis obtained results that were not consistent with previous knowledge. CONCLUSION: MSMs can be used to analyze multiple treatment effects. MSMs, by using inverse-probability of treatment weights, might provide a better control for confounding than conventional methods by improving the adjustment for treatment group differences in observational studies, which may approximate their results to those of randomized controlled trials.
OBJECTIVE: We review marginal structural models (MSMs) and show how they are useful when comparing the effects of multiple treatments on outcomes in observational studies. Until now, MSMs have not been used to compare the effects of more than two treatments. STUDY DESIGN AND SETTING: To illustrate the application of MSMs when patients may receive several treatments, we have reanalyzed the effects of antipsychotic medication on achieving remission in schizophrenia using data from the SOHO study, a 3-year observational study of health outcomes associated with the treatment of schizophrenia. RESULTS: The MSM results were, in general, consistent with but less statistically significant than those obtained using conventional methods. The MSM also showed qualitative differences in some comparisons in which the conventional analysis obtained results that were not consistent with previous knowledge. CONCLUSION: MSMs can be used to analyze multiple treatment effects. MSMs, by using inverse-probability of treatment weights, might provide a better control for confounding than conventional methods by improving the adjustment for treatment group differences in observational studies, which may approximate their results to those of randomized controlled trials.
Authors: David Suarez; Ricard Ferrer; Antonio Artigas; Izaskun Azkarate; José Garnacho-Montero; Gemma Gomà; Mitchell M Levy; Juan Carlos Ruiz Journal: Intensive Care Med Date: 2010-12-09 Impact factor: 17.440
Authors: R C Kessler; H M van Loo; K J Wardenaar; R M Bossarte; L A Brenner; D D Ebert; P de Jonge; A A Nierenberg; A J Rosellini; N A Sampson; R A Schoevers; M A Wilcox; A M Zaslavsky Journal: Epidemiol Psychiatr Sci Date: 2016-01-26 Impact factor: 6.892
Authors: Shikhar Shrestha; Melissa H Roberts; Jessie R Maxwell; Lawrence M Leeman; Ludmila N Bakhireva Journal: Neurotoxicol Teratol Date: 2021-03-23 Impact factor: 4.071
Authors: Melissa H Roberts; Douglas W Mapel; Matthew E Borrego; Dennis W Raisch; Larry Georgopoulos; David van der Goes Journal: Drugs Real World Outcomes Date: 2015-06
Authors: F J Candel; M Borges Sá; S Belda; G Bou; J L Del Pozo; O Estrada; R Ferrer; J González Del Castillo; A Julián-Jiménez; I Martín-Loeches; E Maseda; M Matesanz; P Ramírez; J T Ramos; J Rello; B Suberviola; A Suárez de la Rica; P Vidal Journal: Rev Esp Quimioter Date: 2018-06-25 Impact factor: 1.553